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ABSTRACT
The association of reverse transcriptases (RTs)
with CRISPR–Cas system has recently attracted in-
terest because the RT activity appears to facili-
tate the RT-dependent acquisition of spacers from
RNA molecules. However, our understanding of this
spacer acquisition process remains limited. We char-
acterized the in vivo acquisition of spacers mediated
by an RT-Cas1 fusion protein linked to a type III-
D system from Vibrio vulnificus strain YJ016, and
showed that the adaptation module, consisting of
the RT-Cas1 fusion, two different Cas2 proteins (A
and B) and one of the two CRISPR arrays, was com-
pletely functional in a heterologous host. We found
that mutations of the active site of the RT domain
significantly decreased the acquisition of new spac-
ers and showed that this RT-Cas1-associated adap-
tation module was able to incorporate spacers from
RNA molecules into the CRISPR array. We demon-
strated that the two Cas2 proteins of the adaptation
module were required for spacer acquisition. Fur-
thermore, we found that several sequence-specific
features were required for the acquisition and inte-
gration of spacers derived from any region of the
genome, with no bias along the 5´and 3´ends of cod-
ing sequences. This study provides new insight into
the RT-Cas1 fusion protein-mediated acquisition of
spacers from RNA molecules.
INTRODUCTION
CRISPR–Cas (clustered regularly interspaced short palin-
dromic repeats and CRISPR-associated proteins) systems
are adaptive defense systems that provide acquired immu-
nity against foreign nucleic acids (1). They are present in al-
most all archaea and about 50% of all bacterial genomes
(2,3). CRISPR–Cas systems provide immunity through
three steps: adaptation, expression and interference (4,5).
During the adaptation stage, an integrase complex incor-
porates short DNA or RNA sequences, known as spacers,
into the CRISPR array (6–8). The CRISPR array consists
of repeated sequences (direct repeats) separated by variable
sequences corresponding to the nucleic acid of the invading
agent (spacers). This array is transcribed to generate a pre-
cursor transcript (precursor crRNA) that is processed into
short (mature crRNA) structured RNAs during the expres-
sion stage, leading to the formation of crRNA-Cas effec-
tor complexes that recognize and bind complementary nu-
cleic acids, resulting in degradation of the target molecule,
during the interference step (9–11). These immunogenic sys-
tems are highly diverse and are currently classified into two
broad functional classes, six types and 33 subtypes (12).
The integration complex generally consists of Cas1 and
Cas2 proteins and is largely conserved in all CRISPR–Cas
systems (12). Cas1 seems to originate from a family of trans-
posons called casposons, and it interacts with other proteins
involved in the adaption stage (12–14). One of these ancil-
lary proteins is the reverse transcriptase (RT) responsible
for converting RNA into cDNA (15,16). There are several
groups of prokaryotic RTs. Those closely related to group
II intron-encoded RTs predominate among the RTs asso-
ciated with CRISPR–Cas systems, either separately or fre-
quently via the generation of a natural fusion, at the C-
terminus, with Cas1. These RTs are usually linked to type III
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CRISPR–Cas systems (17,18), which have multisubunit ef-
fector complexes capable of targeting single-stranded RNA
and/or DNA, which must be transcriptionally active (19–
22).
The association of RTs with CRISPR–Cas systems has
recently attracted considerable attention because, in a type
III-B system present in the marine bacterium Marinomonas
mediterranea (MMB-1), the associated Cas6-RT-Cas1 pro-
tein fusion has been shown to facilitate the RT-dependent
acquisition of RNA spacers in vivo through a mechanism
displaying several similarities to group II intron retrohom-
ing (18). An RT-Cas1 fusion associated with a type III-D
system from Fusicatenibacter saccharivorans was recently
shown to acquire RNA spacers efficiently in a heterolo-
gous host (Escherichia coli) and has been used as a tran-
scriptional recorder, describing both continuous and tran-
sient complex cellular behaviors (23). The RTs associated
with CRISPR–Cas systems evolving from group II intron
RTs, which co-evolve with their associated Cas1 protein,
form 13 distinct clades (24,25). The two RT-associated
CRISPR-cas loci studied to date, from M. mediterranea and
F. sacharivorans, belong to clades 8 and 12, respectively.
Thus, our knowledge of the function and mechanisms of the
CRISPR–Cas adaptation modules encoding these RTs re-
mains limited and further studies are required. Exploration
of the diversity of RTs associated with different CRISPR–
Cas systems could also reveal novel properties and potential
biotechnological applications.
We characterized the in vivo acquisition of spacers medi-
ated by a RT-Cas1 fusion protein from clade 6 linked to a
type III-D system from Vibrio vulnificus strain YJ016. Ac-
quisition efficiency was high in only one of the two arrays
present at this locus, and was inversely correlated with the
level of transcription of the CRISPR array. This RT-Cas1-
associated adaptation module was able to incorporate spac-
ers from RNA molecules into the CRISPR array. Further-
more, we found that spacers could be acquired from any
region of the genome, and from within coding sequences,
with no bias along the length of the gene. The nucleotide
sequences of the spacers acquired collectively displayed par-
ticular features potentially related to recognition of the RT-
linked CRISPR adaptation machinery. Our results indicate
that the V. vulnificus type III-D system is a good model for
studying the mechanism of spacer acquisition from RNA
molecules with potential for use as a biotechnological tool.
MATERIALS AND METHODS
Strain and culture conditions
The E. coli strains used in this study were DH5 (Bethesda
Research Lab) for cloning purposes, Rosetta 2 (DE3)
(Novagen) for protein production and HMS 174 (DE3)
for spacer acquisition assays. Bacteria were grown in LB
medium (10 g/l tryptone, 5 g/l yeast extract, 5 g/l NaCl).
Antibiotics were added as required (ampicillin, and tetra-
cycline).
Construction of expression vectors
Plasmids for protein production and purification were
based on the pMal-Flag backbone (Supplementary Table
S1) for RT or RT-Cas1. Plasmids for inducible overexpres-
sion of the adaptation operon of V. vulnificus YJ016 (RT-
Cas1–Cas2A–Cas2B) were built with the pGEM-T Easy
backbone (Promega). The two CRISPR arrays associated
with the two systems, complete or with only the first DR and
the first spacer, were inserted into the pMP220 backbone
(26). RT-Cas1 mutants with mutations of Cas1 (E517A and
E597A) or RT (YADD to YAAA at amino acid positions
220–223) and deletion mutants of Cas2A and Cas2B were
generated, using the pMal-Flag and pGEMT-Easy back-
bones for in vitro and in vivo analyses, respectively. The plas-
mids and oligonucleotides used in this study are listed in
Supplementary Tables S1–S3. All plasmids were verified by
sequencing. Plasmids are available upon request.
Protein purification
We used pMal-Flag derivatives with the different RTs to
transform E. coli strain Rosetta2 (DE3), and single trans-
formed colonies were then grown overnight in LB medium
supplemented with ampicillin, chloramphenicol and 0.2%
glucose, at 37◦C, with shaking. A flask containing 50 ml LB
was inoculated with 1% of the overnight culture, and the
bacteria were grown to exponential growth phase at 37◦C,
with shaking. When the culture reached an optical density
of ∼0.6, IPTG was added to a final concentration of 0.3 mM
and the cultures were incubated overnight at 20◦C. Cells
were harvested by centrifugation, and the pellet was resus-
pended in column buffer (CB: 20 mM Tris–HCl (pH 7.5),
200 mM NaCl, 1 mM EDTA, 1 mM DTT and 1x EDTA-
free protease inhibitor (Roche)) at 4◦C. Cells were lysed by
three freeze-thaw cycles and subjected to sonication (Soni-
fier® Cell Disrupters, Branson Ultrasonics). The lysate was
cleared by centrifugation (16,000 x g, 15 min, 4◦C).
Proteins were purified with a liquid chromatography sys-
tem (BioRad). Different RT or RT-Cas1 fusion proteins
with maltose binding protein (MBP) were purified by load-
ing the filtered crude protein onto an amylose column (30
ml; NEB Amylose High Flow Resin), incubating for 2 h at
4◦C and then washing the column five times with 2 ml CB.
Bound proteins were eluted in CB supplemented with 10
mM maltose. The proteins were concentrated with an Ami-
con ultracentrifugation filter (Ultracel 50-K), and dialyzed
against storage buffer (SB: 10 mM Tris–HCl (pH 7.5), 1 mM
DTT, 50% glycerol). The various proteins were stable in SB
for several months at −20◦C.
All protein concentrations were determined by the Brad-
ford method (BioRad) (27), according to the kit manufac-
turer’s protocol.
RT assay
RT activities were assessed with poly(rA)/oligo(dT)18, pre-
pared by boiling in RT buffer (10 mM KCl, 25 mM MgCl2,
50 mM Tris–HCl (pH 7.5), 5 mM DTT) for 2 min and then
placed on ice. The substrate was incubated with 1mM un-
labeled deoxythimidine triphosphate (dTTP) and 5 Ci [-
32P]dTTP (800 Ci/mmol; GE healthcare) at 37◦C, and the
reaction was initiated by adding the RT or RT-Cas1 pro-
tein (final concentration 0.1–0.5 M) in a final volume of 10
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spotting 8 l of the reaction mixture onto Whatman DE81
paper. The paper was dried and washed in 250 ml of 2×
SSC to eliminate unincorporated labeled dTTP. Radioactiv-
ity was quantified with a scintillation counter (Liquid Scin-
tillation Analyzer Tri-Carb 1500, Packard).
-Galactosidase assay
-Galactosidase assays were performed as described by
Miller (28). Briefly, E. coli DH5 cells were transformed
with the various pCA constructs. Individual transformed
colonies were picked and cultured overnight at 37◦C. Cul-
tures were diluted 1:50 in fresh LB medium and incubated
until the exponential growth phase was reached (OD600
∼0.6). They were then cooled on ice for 20 min and bac-
terial density was recorded by measuring OD600. We then
mixed 100 l of culture with 900 l Z buffer (60 mM
Na2HPO4and 40 mM NaH2PO4 (pH 7.0), 10 mM KCl, 1
mM MgSO4 and 50 mM -mercaptoethanol), 50 l chlo-
roform and 25 l 0.1% SDS) and vortexed the mixture
for 30 seconds. The samples were incubated at 28◦C for
5 min and the reaction was initiated by adding 0.2 ml o-
nitrophenyl--D-galactopyranoside (ONPG). The reaction
mixture was incubated at 28◦C for 10 min and the reac-
tion was then stopped by adding 0.3 M Na2CO3. Samples
were centrifuged for 2 min to eliminate cell debris and ab-
sorbance was measured at 420 nm.
Spacer acquisition assay
Escherichia coli strain HMS174 (DE3) was cotransformed
by electroporation with pAGDt plasmids harboring RT-
Cas1–Cas2A–Cas2B and derivatives, and pCA plasmids
harboring the CRISPR array with only the first DR and the
first spacer (Supplementary Table S1). Individual colonies
were cultured overnight at 37◦C in LB medium supple-
mented with ampicillin and tetracycline. The culture was di-
luted 1:500 in LB medium, and split into triplicates, which
were cultured with the same antibiotics and 0.1 mM IPTG
for 14–18 h. The bacterial cells were harvested by centrifu-
gation and plasmids containing CRISPR arrays were iso-
lated by standard plasmid mini-prep procedures to serve as
a template for PCR amplification and the preparation of
NGS samples.
Amplification of CRISPR arrays and preparation of NGS
samples
Leader proximal spacers were amplified by PCR from 3–
4 ng of plasmid DNA per l of PCR mix, with a forward
primer binding to the leader sequence of the correspond-
ing CRISPR array and a reverse primer binding to the first
native spacer (Supplementary Tables S2 and S3). For each
biological replicate, a 25 l PCR mixture was subjected
to the following cycling sequence: 94◦C for 4 min; 30 cy-
cles of 94◦C for 30 s and 62◦C for 30 s. The dominant
amplicon contained the first native spacer from the unex-
panded CRISPR array. Electrophoresis was performed in
a 2% agarose gel for the excision of gel slices correspond-
ing to a molecular weight of ∼300 bp (70 bp above the
233-bp band, consistent with the expected size of an am-
plicon from the expanded CRISR array). The slices were
purified with the Illustra GFX PCR DNA and Gel Band
Purification Kit (GE Healthcare) and eluted in 30 l of
buffer. We then used 2 l of the eluted product for a sec-
ond round of a semi-nested PCR in a 50 l reaction mix-
ture, with barcoded Illumina sequencing adaptors anneal-
ing to the leader region (closer to the first repeat) and to the
first native spacer (see Supplementary Table S3), as follows:
94◦C for 4 min; 35 cycles of 94◦C for 30 s and 62◦C for 30
s. Expanded CRISPR array amplicons were separated from
unexpanded arrays by an additional round of purification
by electrophoresis in a 2% agarose gel, and the final prod-
uct was eluted in 10 l of buffer. We increased the percent-
age of expanded amplicons by performing a third round of
amplification by gel electrophoresis, for the tdI spacer ac-
quisition assays. The resulting samples were quantified with
Qubit (Life Technologies) and analyzed on a 2100 Bioana-
lyzer (Agilent Technologies). Libraries were sequenced on
an Illumina Miseq at the Genome Sequencing Unit of the
IPBLN-CSIC (Granada, Spain).
Data processing pipeline
FASTQ files were mate-paired with fastq-join
(https://github.com/brwnj/fastq-join), with a minimum
overlap of 40 nt. They were then converted to FASTA
format with FASTX-Toolkit v0.0.14 (fastq-to-fasta)
(htpp://hannolab.cshl.edu/fastx toolkit) and trimmed
with Cutadapt (29). In all samples, ∼90% of total read
pairs were successfully merged, and ∼80% of the merged
read pairs had the correct primer-encoded barcodes located
exactly at the ends of the amplicon. Using a custom script
written in Python v2.7, spacers were identified, grouped
on the basis of unique start and end coordinates (unique
spacers), and mapped on the plasmid and genome with
Bowtie2.0, with two mismatches allowed. This approach
preserves strand information.
Construction and validation of td intron constructs
The 393-bp intron sequence and its native exons
(CTTGGGTCT) were inserted in the SalI restriction
site of the pAGDt-439 plasmid, just downstream from the
adaptation operon, as a SalI/XhoI insertion. The intron
was introduced at this site because we had previously noted
that this was one of the regions of the plasmid into which
new acquisition were preferentially inserted (Supplemen-
tary Figure S5A). In this context, the splicing product
was easy to distinguish from non-spliced transcripts and
DNA. In vivo splicing efficiency assessed by extracting total
RNA and reverse transcribing 1.5 g (SuperScriptII; Life
Technologies) with random hexamers in a 20 l reaction
mixture. We then subjected 1 l of cDNA to amplification
in a 25 l PCR mixture with the Accuprime Polymerase
and the Cas2.2-439f and SP6 primers (Supplementary
Table S2), which bind on either side of the splice site. The
cycling conditions were as follows: 94◦C for 4 min; 35 cycles
of 94◦C for 30 s, 62◦C for 30 s, 72◦C for 40 s; 72◦C for 4
min. The PCR products were analyzed by electrophoresis
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td intron spacer acquisition assay
For the detection of spacers originating from the exon junc-
tion (RNA) after tdI splicing, the spacer acquisition as-
say was optimized by searching for the maximum number
of new different spacers after Illumina-Miseq sequencing.
After cotransformation with pAGDt-439-tdI and pCA2s-
1DR, two different sets corresponding with 80 and 200 in-
dividual colonies were selected for the standard spacer ac-
quisition assay (Supplementary Table S6). Once the plas-
mid DNA had been extracted, individual PCRs were per-
formed, as previously described. The first purification step
was carried out by mixing the PCR products in groups of
10 different colonies, and then performing the second PCR
step. The PCR mixtures were then combined and two band
purification steps were performed to increase the propor-
tion of expanded arrays. With this method, 50–70% of the
reads after Illumina-Miseq sequencing corresponded to the
expanded array, corresponding to >10,000 newly acquired
spacers per assay performed with the tdI construct.
RESULTS
A unique type III-D CRISPR–Cas locus encoding an RT-
Cas1 fusion from V. vulnificus
In our search for functional RT genes linked to CRISPR–
Cas systems, we focused on a unique type III-D CRISPR–
Cas locus from Vibrio vulnificus strain YJ016. The ge-
nomic neighborhood of the RT-Cas1 locus from V. vulnifi-
cus strain YJ016 encoding genes was retrieved, as previ-
ously described (24,25) and spans 21.6 kb on chromosome
II (Figure 1A). This CRISPR–Cas system has an associ-
ated RT-Cas1 fusion protein (690 aa) from CRISPR-RT
clade 6 (25) that displays exogenous RT activity in vitro
(Supplementary Figure S1). A blast search within V. vul-
nificus showed this locus to be located downstream from a
highly conserved operon encoding two peptide-methionine-
S-oxide reductase genes (msrA and msrB) representing an
island (30) within the genome probably acquired by lateral
transfer (Figure 1A). This RT-Cas1 type III-D locus has a
canonical gene-cassette encoding the type-III-D Csm effec-
tor complex including csx19 and cas6 at its 5′ end, tran-
scribed in the opposite direction to the adaptation unit com-
plex constituted by the RT-Cas1 fusion protein and two dif-
ferent Cas2 (A and B) proteins displaying ∼70% identity.
This adaptation module is flanked by two CRISPR arrays:
CRISPR01, with only two spacers, and CRISPR02, with
nine spacers. These two arrays contain identical direct re-
peats (DRs; Figure 1B), and a set of ancillary genes is lo-
cated downstream from the larger CRISPR array. We as-
sessed the promoter activity of the presumed leader region
of the two arrays, by constructing transcriptional fusions of
CRISPR01 and CRISPR02 with a LacZ reporter gene in
E. coli (Figure 1C). Constitutive promoter activity was de-
tected only for the leader sequence of the CRISPR01 array,
consistent with the transcriptional RNAseq data for this
V. vulnificus strain showing that transcription rates for the
CRISPR01 array are several times higher than those for the
CRISPR02 array in various environmental conditions (31;
Supplementary Figure S2).
Spacer acquisition by the V. vulnificus RT-Cas1-associated
CRISPR–Cas adaptation module
We investigated whether the adaptation operon of strain
YJ016 could acquire new spacers in a heterologous host
(E. coli), with expression vectors carrying the genes encod-
ing the RT-Cas1 fusion and the Cas2A and Cas2B pro-
teins and vectors carrying the CRISPR01 or CRISPR02
arrays containing the leader sequence, 1DR and 1 spacer
(Figure 2A). After cotransformation with the two plasmids,
we assessed spacer acquisition in E. coli by overexpressing
the RT-Cas1, Cas2A and Cas2B operon. The acquisition of
new spacers by the two arrays was evident after two rounds
of PCR/purification of the expanded array band, followed
by Illumina-Miseq sequencing. Spacers were acquired from
the E. coli genome (∼95%) with the rest being derived from
plasmids DNA (∼5%) (Supplementary Table S4). Using
this assay, we demonstrated that the strain YJ016 CRISPR–
Cas adaptation module could acquire new spacers in E. coli.
Spacer acquisition by the CRISPR02 array occurred at a
rate about 20 times higher than that for the CRISPR01 ar-
ray (Figure 2B; Supplementary Table S5). Based on these
findings, we used CRISPR02 for further spacer acquisition
assays.
For evaluation of the role of the different domains of
the RT-Cas1 fusion protein in spacer acquisition, we con-
structed two single mutants: one with a YAAA mutation of
the catalytic RT (RT5) and another with an E597A muta-
tion of the Cas1 active site. RT in vitro assays performed (see
method section) revealed that the YAAA mutant lacked RT
activity, whereas the E597A mutant had a level of RT activ-
ity similar to that of the wild-type protein (Supplementary
Figure S3A). The mutants and the wild-type yield similar
amount of protein fusion (Supplementary Figure S3B). The
mutation affecting the Cas1 domain abolished spacer ac-
quisition, whereas the point mutation in the RT active site
decreased the acquisition of new spacers by ∼90% (Figure
2B; Supplementary Figure S3C). These findings reveal the
importance of the functional RT catalytic site in the acqui-
sition of spacers in vivo in the heterologous E. coli host. We
investigated the requirement for Cas2A and/or Cas2B for
the formation of an active acquisition complex in vivo, by
construction deletion mutants of Cas2A, Cas2B or both.
Each deletion completely abolished the acquisition of new
spacers, clearly demonstrating that both Cas2 proteins were
required for the adaptation stage (Figure 2B), and raising
the possibility that the Cas2 dimer of the functional integra-
tion complex consists of two different Cas2 proteins. In fact,
both proteins present the characteristic conserved structure
consisting in 2 alpha helix and 4/5 beta strands in which a
critical aspartic of the catalytic site at the end of the first
beta strand is conserved in both subunits (Supplementary
Figure S4).
Features of the acquired spacers
We investigated the features of the V. vulnificus RT-Cas1-
associated acquisition system, by characterizing the pool
of newly acquired spacers. The spacers matched sequences
throughout the genome of the host bacteria (Figure 3A)
with the rRNA genes as the most abundant in our spacer
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Figure 1. Characteristics of the VvYJ016 type III-D CRISPR operon. (A) Schematic diagram of the type III-D CRISPR–Cas loci in VvYJ016. The
operon consists of a canonical five-gene cassette putatively encoding the type III-B Cmr effector complex (indicated by a beige background) followed by
the gene encoding Cas6, which is involved in crRNA maturation. The opposite strand carries the adaptation module, which consists of an operon of three
genes encoding RT-Cas1 and two Cas2 proteins, located between two CRISPR arrays containing three and nine spacers (CRISPR02). Four ancillary genes
(two csx1 and two csx16) and two genes of unknown function (VVA1542 and VVA1551) complete this CRISPR-island. The black arrows indicate the
array promoters identified. (B) Sequence alignment of the leader sequence and first direct repeat of the VvYJ016 CRISPR01 and CRISPR02 arrays. The
nucleotide sequence of the first repeat is framed by a gray box. The putative promoter of the two sequences is framed by a blue box. The red letters represent
the bases differing between the two sequences. (C) Determination of the level of transcription of the leader sequence of CRISPR01 and CRISPR02. -
Galactosidase activity was measured for the empty plasmid (pMP220) and the two complete arrays, in both orientations with respect to the lacZ gene
(sense: pCA1s; pCA2s for CRISPR01 and CRISPR02, respectively; antisense: pCA1as; pCA2as for CRISPR01 and CRISPR02, respectively). Errors bars
show the standard deviation for three biological replicates.
with a specific antisense orientation of coding sequences,
reflecting the complementary nature of the newly acquired
spacers relative to the predicted messenger RNA (Figure 3A
and B). These findings suggest a relationship between the
orientation of the spacer and transcription, even in the ab-
sence of the effector module.
The spacers were mostly between 34 and 38 base pairs
(bp) long, consistent with the length distribution of the nat-
ural spacers present in these arrays (Figure 3C). Neverthe-
less, spacers originating from plasmids were slightly longer
(1 bp longer on average) than those of genomic origin. Con-
sistent with their origin, the median ‘GC’ content of the
spacers was correlated with the ‘GC’ content of the ‘tem-
plate’ used, either the E. coli genome or the plasmid (Fig-
ure 3D). As in other type III CRISPR–Cas systems (32), no
conserved protospacer-adjacent motif (PAM) was observed
(Figure 4A), even if the analysis was based on dinucleotide
frequency (33; data not shown).
Given the large numbers of different spacers obtained, a
significant deviation of the expected ‘GC’ content was ob-
served at different positions in the spacer unit. Thus, a sym-
metric bias emerged at both ends of the spacers, at which
a stretch of four to five positions rich in ‘AT’ residues was
observed. These ‘AT’-rich positions contrast clearly with
the bias towards ‘GC’ enrichment observed at the first nu-
cleotide of the protospacer flanking the spacer (Figure 4A).
A strong bias towards ‘GC’ was observed at positions +14
and +15 of the spacer (present at ∼67% of the spacers ac-
quired from the genome), and the high frequency of C at
these positions was particularly marked (∼40% of the to-
tal). These specific biases were observed not only for spacers
originating from the genome, but also for those originating
from plasmids, suggesting a probable preference of the ac-
quisition complex. An analysis of the position of the spacer
relative to a coding sequence from the E. coli genome re-
vealed no bias at the beginning or end of the gene (Figure
4B), by contrast observations for the spacer acquisition ma-
chinery of Fusicatenibacter saccharivorans (23). Taken to-
gether, these findings indicate that several sequence-specific
requirements for acquisition and integration are character-
istic of these spacers, regardless of their origin (plasmid or
genome) or relative position in a gene.
The V. vulnificus RT-Cas1-associated CRISPR–Cas adapta-
tion module acquires spacers directly from RNA
We investigated whether the spacers acquired via the RT-
Cas1 system originated from RNA molecules, with an ac-
quisition assay in which we looked for spacers harboring
the ligated exon junction of the self-splicing td group I in-






/nar/article-abstract/47/19/10202/5559687 by guest on 23 July 2020
Nucleic Acids Research, 2019, Vol. 47, No. 19 10207
Figure 2. Spacer acquisition by the VvYJ016 adaptation operon in the heterologous E. coli system. (A) Schematic diagram of the high-throughput
spacer acquisition assay. Overexpression of the adaptation operon in E. coli HMS 174 (DE3) followed by the extraction of plasmid DNA, two rounds
of PCR/purification of the expanded CRISPR array, and deep sequencing, analysis and characterization of the spacers identified. (B) Frequency of new
spacer detection per million reads for the wildtype RT-Cas1, RT active site mutant (YAAA), Cas1 domain mutants E517A and E597A and the Cas2A,
Cas2B and Cas2A-B mutants. The bars indicate the range for three biological replicates.
original transcript and is not present in DNA (18,23), We
designed a construct containing the td intron just down-
stream from the adaptation operon, expressed under the
control of the T7 promoter (Figure 5A). The tdI cloning site
corresponds to a region in which a large number of spac-
ers were observed in the antisense orientation (bias source
transcription; Supplementary Figure S5A), making it more
likely that the spacers detected originated from RNA. We
checked that the exon-junction was not present elsewhere
in the genome. Thus, the detection of the exon junction as
a DNA spacer demonstrates that the system can acquire
spacers directly from RNA. We confirmed that efficient self-
splicing occurred in vivo (almost 100%; Supplementary Fig-
ure S5B). We then performed assays for newly integrated
spacers in plasmid copies of CRISPR02, and we recovered
more than 100,000 new spacers mapping to plasmids or to
the E. coli genome. We found three unique spacers spanning
the splice junction (Figure 5B), confirming that the V. vul-
nificus RT-Cas1-associated CRISPR–Cas adaption module
can acquire spacers from RNA molecules in E. coli.
DISCUSSION
We characterized the acquisition of spacers mediated by an
RT-Cas1 fusion protein associated with a unique type III-
D system from V. vulnificus strain YJ106. We show here
that the adaptation module including the RT-Cas1 fusion,
two different Cas2 proteins (A and B) and two CRISPR ar-
rays is functional in a heterologous host (E. coli). We found
that spacer acquisition differed in efficiency between the
two CRISPR arrays and that it was abolished by mutations
of any of the cas loci and strongly impaired by a lack of
RT activity in the adaptation module. The acquired spacers
throughout the genome, derived from overexpressing plas-
mids and within coding sequences displayed a bias for the
antisense strand. The nucleotide sequence of the acquired
spacers had characteristic features consistent with specific
recognition by the adaptation complex. RT-Cas1 was also
able to acquire spacers from RNA molecules. Overall, our
findings demonstrate that the V. vulnificus type III-D system
is a good model for studying the mechanism of acquisition
of spacers from RNA of potential value for biotechnologi-
cal applications.
Generally, when several CRISPR arrays are present in
a particular CRISPR–Cas locus, only one of them has
a high naı̈ve acquisition efficiency in the systems studied
(23,34). A similar situation was observed here, in the V.
vulnificus YJ016 RT-Cas1 system, as only one of the ar-
rays, CRISPR02, appears to be fully functional in acqui-
sition (Figure 2B). Indeed, CRISPR02 contains more spac-
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Figure 3. Characterization of the spacers acquired by the VvYJ016 adaptation operon. (A) Coverage of spacers aligning with the E. coli HMS174 (DE3)
genome and a representative locus. Identical alignments represent recurrent spacers acquired in independent biological samples (n = 11). (B) Strand bias
in pools of newly acquired spacers relative to the source transcript. Proportion of newly acquired spacers with the Wild-type RT-Cas1 in the sense or
antisense strand of coding genes or in intergenic regions of the E. coli genome (n = 11). (C) Histogram showing normalized counts of E. coli genome
or pAGDt-Op439 plasmid spacers, by length. (D) GC content distribution of genome- and plasmid-aligned spacers. The dotted lines represent the GC
content of the plasmid (light gray) and the genome (dark gray). For C and D, the bars indicate the range for the three assays in which the largest numbers
of spacers were detected (>10,000 newly acquired spacers per experiment).
respectively). An analysis of the leader region revealed only
small differences in sequence more than 119 bp away from
the first DR, so a difference in recognition by the RT-Cas1–
Cas2A–Cas2B complex is highly unlikely. However, the two
arrays displayed a significant difference in promoter activ-
ity, and this activity was inversely correlated with the abil-
ity to acquire new spacers. It is worth noting the oppo-
site has been reported in the E. coli K12 CRISPR system
that the highest expressed CRISPR locus is the most ac-
tive for new spacer acquisition (35,36). Moreover, the small
sequence variations between the CRISPR01 and 02 loci in
V. vulnificus could be due to disruption of binding of other
host factors that may be essential (i.e. IHF or other struc-
tural proteins; 37). The possible relationship between array
transcription levels and spacer acquisition efficiency merits
further study in other systems.
Unlike most of the RT-associated type III CRISPR–
Cas systems (13 out of 14) functionally analyzed by
Schmidt et al. requires of a selective amplification method
(SENECA) to detect the acquisition of new spacers, the
functionality of the RT- CRISPR–Cas system of V. vulnifi-
cus YJ016 can be demonstrated using previously established
spacer acquisition assays (6,18).
Moreover, our results show that the RT domain plays an
essential role in the acquisition step in the heterologous E.
coli host, because the abolition of RT activity greatly de-
creases (by >90%) the number of spacers acquired. A sim-
ilar reduction in an analogous RT mutant has been ob-
served in MMB-1 RT-CRISPR system in M. mediterranea
host but not in E. coli (18). In our experimental condi-
tions the most abundant spacers correspond to rRNA genes
that is the most abundant RNA in the cell, which may re-
flect RNA abundance-dependent spacer acquisition. In the
M. mediterranea system the RT-Cas1 mediated spacer ac-
quisition show a bias towards highly transcribed regions,
but spacers were rarely acquired from rRNA (18). Com-
parisons of our spacer datasets to that of Record-seq (23)
by F. saccharivorans (FsRT-Cas1–Cas2) also obtained in
E. coli does not show any correlation. Additionally, and
in contrast to F. saccharivorans and the M. mediterranea
systems we have not found a positive correlation between
the frequency of spacer acquisition and overall gene ex-
pression level. Note that such correlation does not distin-
guish between spacer acquisition from RNA versus DNA
and only indicates that the acquired spacers are preferen-
tially derived from highly transcribed genes (23). Taken to-
gether, our findings reflect mechanistically specific features
underlying the VvRT-Cas1–Cas2A/Cas2B acquisition sys-
tem that need to be further elucidated. Additionally, consis-
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Figure 4. Spacer composition and position relative to coding sequences.
(A) GC content (above) and nucleotide probabilities (below) at each posi-
tion along the wild-type RT-Cas1–acquired protospacers. Given the varia-
tion of protospacer length, two panels are shown, with the spacer anchored
5´and 3´ at positions 15 and 35, respectively. Spacer (gray background) and
flanking (white background) nucleotides are shown. The dark gray back-
ground indicates asymmetry at the two ends of the spacers, with a stretch of
positions rich in ‘AT’ (see text). The particular bias towards ‘C’ within the
spacer observed is indicated by a red line. The ‘GC’ content is shown for
spacers aligning with the genome (blue) and plasmid (yellow). (B) Gene
body coverage of spacer alignments along the length of transcripts. The
relative position corresponds to the percentile of coding sequence length
± 300 bp of the adjacent genomic regions. Dotted lines in A and B repre-
sent the mean error of alignment for the three assays in which the largest
numbers of spacers were detected (>10,000 newly acquired spacers per ex-
periment).
a bias towards the antisense strand of coding sequences was
observed in the newly acquired spacers in the absence of the
effector unit. This property suggests that, although the RT-
Cas1–Cas2A–Cas2B complex is able to acquire spacers in
either orientation, presents a slight preference of integrat-
ing new spacers into the CRISPR array to generate a cr-
Figure 5. Spacer acquisition from RNA in the VVYJ016 type III-D sys-
tem. (A) Schematic diagram of td intron-containing constructs. We de-
termined whether the spacers originated from RNA, using a self-splicing
transcript that produces an RNA sequence junction not encoded by DNA.
Newly acquired spacers containing this exon junction may be considered to
have been acquired from an RNA target. (B) RNA derived from the newly
acquired exon junction-spanning spacer (blue). The splice site is indicated
by a blue triangle. Red arrows indicate that the spacer are in the antisense
orientation relative to the direction of transcription of the td intron. At the
bottom, the highlighted sequence of one of the splice junction-containing
spacers located in the CRISPR array is indicated.
RNA complementary to predicted transcripts to conduct
to an effective interference in Type III-CRISPR–Cas immu-
nity systems (40).
The presence of two different Cas2 proteins is character-
istic of the RT-CRISPR systems of clade 6 and this set-up is
also frequently observed in clade 13 (24,25). We show here
that both Cas2 proteins are required for spacer acquisition
in vivo raising the possibility that the functional integration
complex carries a Cas2A/Cas2B heterodimeric unit. This
may facilitate analyses of the role of these proteins in the
adaptation stage and may be related with the fact that spac-
ers with a particular sequence are selected, a finding not re-
ported for other RT–CRISPR–Cas systems characterized
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scribed for type I CRISPR–Cas systems, Cas2 dimer plays
a structural role in the formation and stabilization of the
adaptation complex, binding the central area of the pro-
tospacer and acting as a bridge between two Cas1 dimers
(8,41). By analogy, in our system, the bias observed at dif-
ferent positions within the newly acquired spacers may indi-
cate that, within the RT-Cas1–Cas2A–Cas2B complex, the
RT-Cas1 protein preferentially binds to spacers with bor-
ders rich in ‘AT’ and flanked by a ‘G’ or a ‘C’ at the derived
protospacer, whereas the Cas2A–Cas2B heterodimeric unit
may be responsible for the particular bias (towards ‘C’) ob-
served at asymmetric positions (+14 and +15) within the
spacer, further studies are required to validate this hypoth-
esis.
Finally, the use of the F. saccharivorans RT-Cas1–Cas2
system as an RNA-recording tool appears to result in skew-
ing to AT-rich regions at the ends of the transcripts (23),
whereas the V. vulnificus RT-Cas1–Cas2A–Cas2B system
can acquire spacers regardless of their ‘GC’ content and
from any point in the coding sequence.
In summary, the RT-Cas1 system from V. vulnificus
YJ016 is a new RT–CRISPR system with novel proper-
ties different from those of the systems previously studied
(18,23). It is a good model for further studies not only of the
role of RTs in the acquisition of spacers, but also for eluci-
dating the particular role of heterologous Cas2 complexes
and the characteristics of the spacers acquired by type III
CRISPR–Cas systems.
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